Fetal Alcohol Spectrum Disorders Clinical Trial
Official title:
Development of an Epigenetic Biomarker for Prediction of Fetal Alcohol Spectrum Disorder
The objective of the study is to validate epigenetic changes as biomarkers in a prospective sampling of newborn blood samples collected at birth (umbilical cord blood) and during routine screening (heel stick blood) in newborns concurrently tested for alcohol exposure levels by PEth blood spot testing.
Fetal alcohol spectrum disorders (FASD) are a group of conditions that can occur in a person whose birth mother consumed alcohol during pregnancy. The effects can include physical problems and/or difficulties with behavior and learning. When clinicians identify FASD early, intervention approaches can minimize the potential impact and lessen or even prevent disabilities. Thus, objective markers for prenatal alcohol exposure are desired. Using dried blood spots from the umbilical cord and a heel stick of newborns, this study will use Phosphatidylethanol (PEth), a novel biomarker for alcohol exposure, to identify and characterize infants' exposure to alcohol before birth. Additionally, the dried blood spots will used to validate the use of screening assays using epigenetic changes as markers for prenatal alcohol exposure. Epigenetic changes are heritable changes in DNA that affect DNA function but do not change DNA sequence. The use of PEth testing will allow for the correlation of prenatal alcohol exposure levels with epigenetic changes. Women will be consented prior to delivery for participation in this prospective study. The study will be conducted in collaboration with United States Drug Testing Laboratories, Inc. (USDTL). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01961050 -
Preventing FAS/ARND in Russian Children
|
N/A | |
| Recruiting |
NCT05108974 -
Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study
|
Phase 2 | |
| Completed |
NCT02457676 -
Improving Self Regulation in Children With Fetal Alcohol Syndrome Spectrum Disorders: A Neuroplastic Intervention
|
N/A | |
| Recruiting |
NCT06005181 -
The Synchrony Study: Examining Music Training for Children With FASD
|
N/A | |
| Completed |
NCT04571463 -
Ethyl Glucuronide in Urine Samples of Pregnant Women Within the HUS ja PHHYKY Area
|
||
| Completed |
NCT03361293 -
Cognitive Training and tDCS for Children With FASD
|
N/A | |
| Recruiting |
NCT05534568 -
The Oklahoma Parent-Child Assistance Program
|
N/A | |
| Recruiting |
NCT05456321 -
CIFASD 5 tDCS and Cognitive Training
|
N/A | |
| Completed |
NCT01911299 -
Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders
|
Phase 2 | |
| Recruiting |
NCT04332172 -
Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy
|
N/A | |
| Completed |
NCT05604014 -
Feasibility Study of the My Health Coach App for Adults With FASD
|
N/A | |
| Recruiting |
NCT05960461 -
Families Moving Forward (FMF) Connect Pro for Mental Health Providers
|
N/A | |
| Terminated |
NCT03852550 -
READYorNot[TM] Brain-Based Disabilities Trial
|
N/A | |
| Completed |
NCT02735473 -
Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders
|
Phase 2 | |
| Completed |
NCT03782935 -
Nutritional Risk Factors for FASD in Ukraine
|
N/A | |
| Not yet recruiting |
NCT04918043 -
Alcohol Use During Pregnancy in Finland According to Meconium Samples
|
||
| Completed |
NCT04072809 -
Dissecting the Genetics of Fetal Alcohol Spectrum Disorders
|
||
| Completed |
NCT01149538 -
Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure
|
Phase 1/Phase 2 | |
| Completed |
NCT05028517 -
Efficacy Trial of the FMF Connect Mobile Health Intervention
|
N/A | |
| Completed |
NCT04194489 -
Trial of the Families Moving Forward (FMF) Connect Mobile Health Intervention
|
N/A |